CENPU is reported to be abnormally high expressed in various human tumor tissues and is involved in tumor progression, such as prostate cancer, breast cancer, bladder cancer, and ovarian cancer, and its overexpression has been shown to predict poor prognosis [20–22]. Here, CENPU is linked to prostate cancer.